Skip to Content

PROGRAF HARD CAPSULES 0.5MG

Active substance(s): TACROLIMUS

View full screen / Print PDF » Download PDF ⇩
Transcript
Package leaflet: Information for the user

146948 GBprogLFT

Prograf® 0.5 mg hard capsules
Prograf® 1 mg hard capsules
Prograf® 5 mg hard capsules

Prograf CAP

Tacrolimus

148x610mm

Great Britain
LFT_215 FD

Read all of this leaflet carefully before you start taking this medicine because it contains
important information for you.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not pass it on to others. It may harm them,
even if their signs of illness are the same as yours.
- If you get any side effects, talk to your doctor or pharmacist. This includes any possible side
effects not listed in this leaflet. See section 4.

23.06.15/15:28

VTB 5573

Eq. to: N/A

What is in this leaflet
1. What Prograf® is and what it is used for
2. What you need to know before you take Prograf®
3. How to take Prograf®
4. Possible side effects
5. How to store Prograf®
6. Contents of the pack and other information
1.

black

What Prograf® is and what it is used for

Prograf belongs to a group of medicines called immunosuppressants. Following your organ
transplant (e.g. liver, kidney, heart), your body’s immune system will try to reject the new organ.
Prograf® is used to control your body’s immune response enabling your body to accept the
transplanted organ.
Prograf® is often used in combination with other medicines that also suppress the immune system.
®

You may also be given Prograf® for an ongoing rejection of your transplanted liver, kidney, heart or
other organ or if any previous treatment you were taking was unable to control this immune response
after your transplantation.
2.

What you need to know before you take Prograf®

Do not take Prograf®
- If you are allergic (hypersensitive) to tacrolimus or any of the other ingredients of Prograf®
(listed in section 6).
- If you are allergic (hypersensitive) to any antibiotic belonging to the subgroup of macrolide
antibiotics (e.g. erythromycin, clarithromycin, josamycin).

Other medicines and Prograf®
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other
medicines, including medicines obtained without a prescription and herbal remedies.

146948 GBprogLFT

Warnings and precautions
Talk to your doctor or pharmacist before taking Prograf®
- You will need to take Prograf® every day as long as you need immunosuppression to prevent
rejection of your transplanted organ. You should keep in regular contact with your doctor.
- Whilst you are taking Prograf® your doctor may want to carry out a number of tests (including
blood, urine, heart function, visual and neurological tests) from time to time. This is quite normal
and will help your doctor to decide on the most appropriate dose of Prograf® for you.
- Please avoid taking any herbal remedies, e.g. St. John’s wort (Hypericum perforatum) or any
other herbal products as this may affect the effectiveness and the dose of Prograf® that you
need to receive. If in doubt please consult your doctor prior to taking any herbal products or
remedies.
- If you have liver problems or have had a disease which may have affected your liver, please tell
your doctor as this may affect the dose of Prograf® that you receive.
- If you feel strong abdominal pain accompanied or not with other symptoms, such as chills,
fever, nausea or vomiting.
- If you have diarrhoea for more than one day, please tell your doctor, because it might be
necessary to adapt the dose of Prograf® that you receive.
- If you have an alteration of the electrical activity of your heart called “QT prolongation”.
- Limit your exposure to sunlight and UV light whilst taking Prograf® by wearing appropriate
protective clothing and using a sunscreen with a high sun protection factor. This is because of
the potential risk of malignant skin changes with immunosuppressive therapy.
- If you need to have any vaccinations, please inform your doctor
beforehand. Your doctor will advise you on the best course of
action.
- Patients treated with Prograf® have been reported to have an
increased risk of developing lymphoproliferative disorders (see
section 4). Ask your doctor for specific advice on these disorders.

Prograf® must not be taken with ciclosporin.
Prograf® blood levels can be affected by other medicines you take, and blood levels of other
medicines can be affected by taking Prograf® which may require interruption, an increase or
a decrease in Prograf® dose. In particular, you should tell your doctor if you are taking or have
recently taken medicines with active substances like:
- antifungal medicines and antibiotics (particularly so-called macrolide antibiotics) used to treat
infections e.g. ketoconazole, fluconazole, itraconazole, voriconazole, clotrimazole,
erythromycin, clarithromycin, josamycin, and rifampicin
- HIV protease inhibitors (e.g. ritonavir, nelfinavir, saquinavir), used to treat HIV infection
- HCV protease inhibitors (e.g. telaprevir, boceprevir), used to treat hepatitis C infection
- medicines for stomach ulcer and acid reflux (e.g. omeprazole, lansoprazole or cimetidine)
- antiemetics, used to treat nausea and vomiting (e.g. metoclopramide)
- magnesium-aluminium-hydroxide (antacid), used to treat heartburn
- hormone treatments with ethinylestradiol (e.g. the oral contraceptive pill) or danazol
- medicines for high blood pressure or heart problems such as nifedipine, nicardipine, diltiazem
and verapamil
- anti-arrhythmic medicines (amiodarone) used to control arrhythmia (uneven beating of the
heart)
- medicines known as “statins” used to treat elevated cholesterol and triglycerides
- the anti-epileptic medicines phenytoin or phenobarbital
- the corticosteroids prednisolone and methylprednisolone
- the anti-depressant nefazodone
- herbal preparations containing St. John's Wort (Hypericum perforatum) or extracts of
Schisandra sphenanthera.
Tell your doctor if you are taking or need to take ibuprofen, amphotericin B, or antivirals (e.g. aciclovir).
These may worsen kidney or nervous system problems when taken together with Prograf®.
Your doctor also needs to know if you are taking potassium supplements or potassium-sparing
diuretics (e.g., amiloride, triamterene, or spironolactone), certain pain killers (so-called NSAIDs,
e.g. ibuprofen), anticoagulants, or oral medication for diabetic treatment, while you take Prograf®.
If you need to have any vaccinations, please inform your doctor beforehand.
Prograf® with food and drink
You should generally take Prograf® on an empty stomach or at least 1 hour before or 2 to 3 hours
after a meal. Grapefruit and grapefruit juice should be avoided while taking Prograf®.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask
your doctor or pharmacist for advice before taking this medicine.
Prograf® is excreted into breast milk. Therefore you should not breast-feed whilst receiving Prograf®.
Driving and using machines
Do not drive or use any tools or machines if you feel dizzy or sleepy, or have problems seeing clearly
after taking Prograf®. These effects are more frequently observed if Prograf® is taken in conjunction
with alcohol use.
Prograf® contains lactose and lecithin (soya)
Prograf® contains lactose. If you have been told by your doctor that you have an intolerance to some
sugars, contact your doctor before taking this medicinal product.
The printing ink used on Prograf® capsules 0.5 mg and 1 mg contains soya lecithin. If you are
allergic to peanut or soya, talk to your doctor to determine whether you should use this medicine.
3. How to take Prograf®
Always take Prograf® exactly as your doctor has told you. You should check with your doctor or
pharmacist if you are not sure.
Make sure that you receive the same tacrolimus medicine every time you collect your prescription,
unless your transplant specialist has agreed to change to a different tacrolimus medicine.
This medicine should be taken twice a day. If the appearance of this medicine is not the same as
usual, or if dosage instructions have changed, speak to your doctor or pharmacist as soon as
possible to make sure that you have the right medicine.
The starting dose to prevent the rejection of your transplanted organ will be determined by your
doctor calculated according to your body weight. Initial doses just after transplantation will generally
be in the range of
0.075 – 0.30 mg per kg body weight per day
depending on the transplanted organ.
Your dose depends on your general condition and on which other immunosuppressive medication
you are taking. Regular blood tests by your doctor will be required to define the correct dose and to
adjust the dose from time to time. Your doctor will usually reduce your Prograf® dose once your
condition has stabilised. Your doctor will tell you exactly how many capsules to take and how often.
Prograf® is taken orally twice daily, usually in the morning and evening. You should generally take
Prograf® on an empty stomach or at least 1 hour before or 2 to 3 hours after the meal. The capsules
should be swallowed whole with a glass of water. Take the capsules immediately following removal
from the blister. Avoid grapefruit and grapefruit juice while taking Prograf®. Do not swallow the
desiccant contained in the foil wrapper.
If you take more Prograf® than you should
If you have accidentally taken too much Prograf® see your doctor or contact your nearest hospital
emergency department immediately.
If you forget to take Prograf®
Do not take a double dose to make up for forgotten individual doses.
If you have forgotten to take your Prograf® capsules, wait until it is time for the next dose, and then
continue as before.
If you stop taking Prograf®
Stopping your treatment with Prograf® may increase the risk of rejection of your transplanted organ.
Do not stop your treatment unless your doctor tells you to do so.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, Prograf® can cause side effects, although not everybody gets them.
Prograf® reduces your body’s own defence mechanism to stop you rejecting your transplanted
organ. Consequently, your body will not be as good as usual at fighting infections. So if you are
taking Prograf® you may therefore catch more infections than usual such as infections of the skin,
mouth, stomach and intestines, lungs and urinary tract.
Severe side effects may occur, including the ones listed below. Tell your doctor immediately if you
have or suspect you may have any of the following serious side effects:
- Opportunistic infections (bacterial, fungal, viral and protozoal): prolonged diarrhea, fever and
sore throat.
- Benign and malignant tumours have been reported following treatment as a result of
immunosuppression.
- Thrombotic Thrombocytopenic Purpura (or TTP) a condition characterised by fever and
bruising under the skin that may appear as red pinpoint dots, with or without unexplained

Free Information Service
Dear Patient,
Your doctor has prescribed you Prograf® to help treat your organ transplant.
To help ensure you have as much information as possible about your condition,
Astellas Pharma Ltd has produced a selection of booklets called the PA Transplantation
Support Service. The information service is free and has been produced with the help of
transplant nurses and transplant coordinators.
If you would like more information about this information service, please talk to your
transplant team.

146948 GBprogLFT.indd 1

23-06-15 15:29

PMS 485 C

-

-
-
-
-
-
-
-
-
-

extreme tiredness, confusion, yellowing of the skin or eyes (jaundice), with symptoms of acute
renal failure (low or no urine output).
Cases of pure red cell aplasia (a very severe reduction in red blood cell counts) and haemolytic
anaemia (decreased number of red blood cells due to abnormal breakdown accompanied with
tiredness) have been reported. You may have no symptoms or depending on the severity of the
condition, you may feel: fatigue, apathy, abnormal paleness of the skin (pallor), shortness of
breath, dizziness, headache, chest pain and coldness in hands and feet.
Cases of agranulocytosis (a severely lowered number of white blood cells accompanied with
ulcers in the mouth, fever and infection(s)). You may have no symptoms or you may feel sudden
fever, rigors and sore throat.
Allergic and anaphylactic reactions with the following symptoms: a sudden itchy rash (hives),
swelling of hands, feet, ankle, face, lips, mouth or throat (which may cause difficulty in
swallowing or breathing) and you may feel you are going to faint.
Posterior Reversible Encephalopathy Syndrome (PRES): headache, altered mental status,
seizures, and visual disturbances.
Torsades de Pointes: change in the heart frequency that can be accompanied or not by
symptoms, such as chest pain (angina), faint, vertigo or nausea, palpitations (feeling the
heartbeat) and difficulty breathing.
Gastrointestinal perforation: strong abdominal pain accompanied or not with other symptoms,
such as chills, fever, nausea or vomiting.
Stevens-Johnson syndrome: unexplained widespread skin pain, facial swelling, serious illness
with blistering of skin, mouth, eyes and genitals, hives, tongue swelling, red or purple skin rash
that spreads, skin shedding.
Toxic epidermal necrolysis: erosion and blistering of skin or mucous membranes, red swollen
skin that can detach in large parts of the body.
Haemolytic uraemic syndrome, a condition with the following symptoms: low or no urine output
(acute renal failure), extreme tiredness, yellowing of the skin or eyes (jaudince) and abnormal
bruising or bleeding and signs of infection.
Insufficient function of your transplanted organ

The side effects listed below may also occur after receiving Prograf®:
Very common side effects (may affect more than 1 in 10 people):
- Increased blood sugar, diabetes mellitus, increased potassium in the blood
- Difficulty in sleeping
- Trembling, headache
- Increased blood pressure
- Diarrhoea, nausea
- Kidney problems
Common side effects (may affect up to 1 in 10 people):
- Reduced magnesium, phosphate, potassium, calcium or sodium in the blood, fluid overload,
increased uric acid or lipids in the blood, decreased appetite, increased acidity of the blood,
other changes in the blood salts
- Anxiety symptoms, confusion and disorientation, depression, mood changes, nightmare,
hallucination, mental disorders
- Fits, disturbances in consciousness, tingling and numbness (sometimes painful) in the hands
and feet, dizziness, impaired writing ability, nervous system disorders
- Blurred vision, increased sensitivity to light, eye disorders
- Ringing sound in your ears
- Reduced blood flow in the heart vessels, faster heartbeat
- Bleeding, partial or complete blocking of blood vessels, reduced blood pressure
- Shortness in breath, changes in the lung tissue, collection of liquid around the lung, inflammation
of the pharynx, cough, flu-like symptoms
- Inflammations or ulcers causing abdominal pain or diarrhoea, bleeds in the stomach,
inflammations or ulcers in the mouth, collection of fluid in the belly, vomiting, abdominal pains,
indigestion, constipation, flatulence, bloating, loose stools, stomach problems
- Changes in liver enzymes and function, yellowing of the skin due to liver problems, liver tissue
damage and inflammation of the liver
- Itching, rash, hair loss, acne, increased sweating
- Pain in joints, limbs or back, muscle spasms
- Insufficient function of the kidneys, reduced production of urine, impaired or painful urination
- General weakness, fever, collection of fluid in your body, pain and discomfort, increase of the
enzyme alkaline phosphatase in your blood, weight gain, feeling of temperature disturbed
Uncommon side effects (may affect up to 1 in 100 people):
- Changes in blood clotting, reduction in all blood cell counts
- Dehydration, reduced protein or sugar in the blood, increased phosphate in the blood
- Coma, bleeding in the brain, stroke, paralysis, brain disorder, speech and language
abnormalities, memory problems
- Blurring of the vision due to abnormality in the lens of the eye
- Impaired hearing
- Irregular heartbeat, stop of heartbeat, reduced performance of your heart, disorder of the heart
muscle, enlargement of the heart muscle, stronger heartbeat, abnormal ECG, heart rate and
pulse abnormal
- Blood clot in a vein of a limb, shock
- Difficulties in breathing, respiratory tract disorders, asthma
- Obstruction of the gut, increased blood level of the enzyme amylase, reflux of stomach content
in your throat, delayed emptying of the stomach
- Dermatitis, burning sensation in the sunlight
- Joint disorders
- Inability to urinate, painful menstruation and abnormal menstrual bleeding
- Failure of some organs, influenza like illness, increased sensitivity to heat and cold, feeling of
pressure on your chest, jittery or abnormal feeling, increase of the enzyme lactate
dehydrogenase in your blood, weight loss
Rare side effects (may affect up to 1 in 1,000 people):
- Small bleeds in your skin due to blood clots
- Increased muscle stiffness
- Blindness
- Deafness
- Collection of fluid around the heart
- Acute breathlessness
- Cyst formation in your pancreas
- Problems with blood flow in the liver
- Increased hairiness
- Thirst, fall, feeling of tightness in your chest, decreased mobility, ulcer
Very rare side effects (may affect up to 1 in 10,000 people):
- Muscular weakness
- Echocardiogram abnormal
- Liver failure, narrowing of the bile vessel
- Painful urination with blood in the urine
- Increase of fat tissue
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any side effects not
listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at:
www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on
the safety of this medicine.
5. How to store Prograf®
Keep Prograf® out of the sight and reach of children.
Take the hard capsules immediately following removal from the blister.
Do not use Prograf® after the expiry date which is stated on the carton and blister after EXP.
The expiry date refers to the last day of that month. Use all the capsules within 1 year of opening the
aluminium wrapping.
This medicinal product does not require any special temperature storage conditions.
Store in the original package in order to protect from moisture.
6. Contents of the pack and other information
What Prograf® contains
Prograf® 0.5 mg hard capsules
- The active substance is tacrolimus. Each capsule contains 0.5 mg of tacrolimus as tacrolimus
monohydrate.
- The other ingredients are:
Capsule content: Hypromellose, croscarmellose sodium, lactose monohydrate, magnesium
stearate.

Capsule shell: Titanium dioxide (E 171), yellow iron oxide (E 172), gelatine.

Printing ink of capsule shell: Shellac, lecithin (soya), hydroxypropyl cellulose, simeticone, red
iron oxide (E 172).
Prograf® 1 mg hard capsules
- The active substance is tacrolimus. Each capsule contains 1 mg of tacrolimus as tacrolimus
monohydrate.
- The other ingredients are:
Capsule content: Hypromellose, croscarmellose sodium, lactose monohydrate, magnesium
stearate.

Capsule shell: Titanium dioxide (E 171), gelatine.

Printing ink of capsule shell: Shellac, lecithin (soya), hydroxypropyl cellulose, simeticone, red
iron oxide (E 172).
Prograf® 5 mg hard capsules
- The active substance is tacrolimus. Each capsule contains 5 mg of tacrolimus as tacrolimus
monohydrate.
- The other ingredients are:
Capsule content: Hypromellose, croscarmellose sodium, lactose monohydrate, magnesium
stearate.

Capsule shell: Titanium dioxide (E 171), red iron oxide (E 172), gelatine.

Printing ink of capsule shell: Shellac, titanium dioxide (E 171) and propylene glycol.
What Prograf® looks like and contents of the pack
Prograf® 0.5 mg hard capsules
Opaque light yellow capsules imprinted in red with "0.5 mg" and "[f] 607", containing white powder.
Prograf® 0.5 mg hard capsules are supplied as blister strips or perforated unit-dose blister strips
containing 10 capsules within a protective foil wrapper, including a desiccant protecting the
capsules from moisture. The desiccant should not be swallowed.Packs of 20, 30, 50, 60 and 100
hard capsules are available in blister strips and packs of 20×1, 30×1, 50×1, 60×1 and 100×1 hard
capsules are available in unit-dose blister strips.
Prograf® 1 mg hard capsules
Opaque white capsules imprinted in red with "1 mg" and "[f] 617", containing white powder.
Prograf® 1 mg hard capsules are supplied as blister strips or perforated unit-dose blister strips
containing 10 capsules within a protective foil wrapper, including a desiccant protecting the
capsules from moisture. The desiccant should not be swallowed. Packs of 20, 30, 50, 60, 90 and
100 hard capsules are available in blister strips and packs of 20×1, 30×1, 50×1, 60×1, 90×1 and
100×1 hard capsules are available in unit-dose blister strips.
Prograf® 5 mg hard capsules
Opaque greyish red capsules imprinted in white with "5 mg" and "[f] 657", containing white powder.
Prograf® 5 mg hard capsules are supplied as blister strips or perforated unit-dose blister strips
containing 10 capsules within a protective foil wrapper, including a desiccant protecting the
capsules from moisture. The desiccant should not be swallowed. Packs of 30, 50, 60 and 100 hard
capsules are available in blister strips and packs of 30×1, 50×1, 60×1 and 100×1 hard capsules are
available in unit-dose blister strips.
Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder:
Astellas Pharma Ltd.
2000 Hillswood Drive
Chertsey
Surrey
KT16 0RS
UK.
Manufacturer:
Astellas Ireland Co. Ltd.
Killorglin
County Kerry
Ireland
This medicinal product is authorised in the Member States of the EEA under the following
names:
Prograf®:
Austria, Cyprus, Czech Republic, Denmark, Germany, Greece, Spain, Finland, France, Hungary,
Ireland, Italy, Malta, Norway, Poland, Portugal, Slovakia, Slovenia, Sweden, United Kingdom.
Prograft®:
Belgium, Luxembourg, The Netherlands.
This leaflet was last revised in 06/2015.

146948 GBprogLFT.indd 2

146948 GBprogLFT

23-06-15 15:29

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide